These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 17059445

  • 1. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis.
    Murray ML, Cohen JB.
    Clin Exp Dermatol; 2007 Jan; 32(1):23-7. PubMed ID: 17059445
    [Abstract] [Full Text] [Related]

  • 2. [Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients].
    Ballester I, Silvestre JF, Pérez-Crespo M, Lucas A.
    Actas Dermosifiliogr; 2009 Dec; 100(10):883-7. PubMed ID: 20038365
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients.
    Heller M, Shin HT, Orlow SJ, Schaffer JV.
    Br J Dermatol; 2007 Jul; 157(1):127-32. PubMed ID: 17489974
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate Mofetil in Severe Atopic Dermatitis: A Review.
    Prussick L, Plotnikova N, Gottlieb A.
    J Drugs Dermatol; 2016 Jun 01; 15(6):715-8. PubMed ID: 27272078
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis.
    Dias-Polak D, Bergman R, Avitan-Hersh E.
    J Dermatolog Treat; 2019 Feb 01; 30(1):49-51. PubMed ID: 29683760
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil is effective in the treatment of atopic dermatitis.
    Grundmann-Kollmann M, Podda M, Ochsendorf F, Boehncke WH, Kaufmann R, Zollner TM.
    Arch Dermatol; 2001 Jul 01; 137(7):870-3. PubMed ID: 11453805
    [Abstract] [Full Text] [Related]

  • 7. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
    van Velsen SG, Haeck IM, Bruijnzeel-Koomen CA, de Bruin-Weller MS.
    Br J Dermatol; 2009 Mar 01; 160(3):687-91. PubMed ID: 19120337
    [Abstract] [Full Text] [Related]

  • 8. Treatment of atopic eczema with oral mycophenolate mofetil.
    Neuber K, Schwartz I, Itschert G, Dieck AT.
    Br J Dermatol; 2000 Aug 01; 143(2):385-91. PubMed ID: 10951150
    [Abstract] [Full Text] [Related]

  • 9. An analysis of the dermatological uses of mycophenolate mofetil in a tertiary hospital.
    George L, Hamann I, Chen K, Choi J, Fernandez-Peñas P.
    J Dermatolog Treat; 2015 Feb 01; 26(1):63-6. PubMed ID: 24286467
    [Abstract] [Full Text] [Related]

  • 10. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
    Garritsen FM, Roekevisch E, van der Schaft J, Deinum J, Spuls PI, de Bruin-Weller MS.
    J Eur Acad Dermatol Venereol; 2015 Oct 01; 29(10):1905-12. PubMed ID: 25752497
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR.
    Ophthalmology; 2003 Sep 01; 110(9):1750-5. PubMed ID: 13129873
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis.
    Nihtyanova SI, Brough GM, Black CM, Denton CP.
    Rheumatology (Oxford); 2007 Mar 01; 46(3):442-5. PubMed ID: 16899504
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil and skin diseases.
    Hartmann M, Enk A.
    Lupus; 2005 Mar 01; 14 Suppl 1():s58-63. PubMed ID: 15803935
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B, Chen N, Lin Y, Ren H, Zhang W, Wang W, Pan X, Yu H.
    Nephrol Dial Transplant; 2007 Jul 01; 22(7):1933-42. PubMed ID: 17405792
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil for the treatment of chronic dermatitis: an open-label study of 16 patients.
    Jackson JM, Fowler JF, Callen JP, Lorenz DJ.
    J Drugs Dermatol; 2010 Apr 01; 9(4):356-62. PubMed ID: 20514793
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
    Siepmann K, Huber M, Stübiger N, Deuter C, Zierhut M.
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul 01; 244(7):788-94. PubMed ID: 16163494
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil therapy for refractory inflammatory bowel disease.
    Palaniappan S, Ford AC, Greer D, Everett SM, Chalmers DM, Axon AT, Hamlin PJ.
    Inflamm Bowel Dis; 2007 Dec 01; 13(12):1488-92. PubMed ID: 17924566
    [Abstract] [Full Text] [Related]

  • 18. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
    Greiner K, Varikkara M, Santiago C, Forrester JV.
    Ophthalmologe; 2002 Sep 01; 99(9):691-4. PubMed ID: 12219257
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
    Orth T, Peters M, Schlaak JF, Krummenauer F, Wanitschke R, Mayet WJ, Galle PR, Neurath MF.
    Am J Gastroenterol; 2000 May 01; 95(5):1201-7. PubMed ID: 10811328
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W, Liu C, Xie H, Chen H, Liu Z, Li L.
    Nephrol Dial Transplant; 2008 Apr 01; 23(4):1307-12. PubMed ID: 18065810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.